Patent · US Active

Use of a synergistic combination of hypothiocyanite and/or hypohalite ions and lactoferrin for preparing a treatment for cystic fibrosis

US9078859B2 · kind B2 · utility

0Cited by

2References

7Claims

0Family size

Assignee

ALAXIA · FR

Inventors

Philippe Bordeau · Mions, FR
Jean-Paul Perraudin · Dilbeek, BE

Key dates

Filing date	Jan 28, 2010
Grant date	Jul 14, 2015
Priority date	—
Expiry date	Jan 27, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P31/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to the use of a synergistic combination of at least one ion selected from the group including hypothiocyanites and/or hypohalites and of lactoferrin for preparing a pharmaceutical composition for treating cystic fibrosis. In one embodiment, the lactoferrin is one having a purity higher than 95% and substantially free of lipopolysaccharides, endotoxins, and angiogenins, and having an iron saturation level higher than 15%.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.